|
|
|
|
| Strategy |
 |
|
Launch for Long-Term Success |
Is a fast launch the only path to a high-value product? Surprisingly, the answer is no. A study by The Boston Consulting Group looks at why a pharma brand's early sales are not a trusted predictor for total lifetime value—it's about driving waves of growth
... /Read more/ |
|
|
| Pricing |
 |
|
Another European Drug Pricing Spat |
The external reference pricing circus has rolled back into town, promising another great European show. The fight-back comes via one of Europe's most obscure bodies, the European Integrated Price Information Database—better known as Euripid. Reflector reports
... /Read more/ |
|
|
|
|
|
| Industry update |
| //GammaDelta Therapeutics Ltd (London, UK) appointed Paolo Paoletti, M.D, as Chief Executive Officer, and Natalie Mount, Ph.D, as Chief Scientific Officer.//Neil Clark stepped down as a Director of Ergomed (London, UK) in April 2017 to become Chief Executive Officer of Destiny Pharma (Brighton, UK). //Dr. Claudia Roth was appointed to the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart, Germany.//ProQR Therapeutics (Lieden, The Netherlands) appointed David M. Rodman, MD as Chief Development Strategy Officer. // |
|
|
|
